+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Legal Marijuana Market Size, Share & Trends Analysis Report by Application (Medical, Adult Use), Product Type (Flower, Oils and Tinctures), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 125 Pages
  • January 2024
  • Region: Global
  • Grand View Research
  • ID: 4538866
Description Jump to:
The global legal marijuana market is expected to reach USD 102.24 billion by 2030. The market is expected to expand at a CAGR of 25.7% from 2024 to 2030. Increase in rate of legalization of marijuana for medicinal and adult-use/recreational marijuana, growing adoption of these products for the treatment of chronic ailments and rise in a number of new product launches are the primary factors responsible for the growth of the market. For instance, in March 2023, Irwin Naturals Inc., a herbal supplement formulator, introduced company's’ new CBD 25mg Softgels in Canada. It is available through the Starseed Medicinal Medical Group platform across the nation.

In April 2022, New Jersey legalized recreational and medical marijuana, and it is being sold at 13 facilities. This move has made New Jersey one of the 18 states in the United States where recreational marijuana is legal. The market is experiencing growth due to the widespread acceptance of cannabis and its high demand. Since its legalization, the use of marijuana in medical treatments has increased, leading to a decrease in the illegal trade of cannabis. According to a study conducted by New York University, the usage of cannabis among individuals aged 50-64 has doubled in the last decade and has now reached 9%.

Moreover, price of legal marijuana is lower than medical marijuana, and taxes would be levied on marijuana products after its legalization. Therefore, cultivators are focusing on cultivating marijuana in areas that are exempt from taxes. For instance, in New York, marijuana cultivators are focusing on tribal regions to get exempted from the taxes levied by the government. This is expected to lower the overall cost of cultivation of marijuana in the state, and cultivators can sell marijuana at lower prices. Lower prices of marijuana are further anticipated to boost the adoption of marijuana in the market.

Legal Marijuana Market Report Highlights

  • By application, medical segment accounted for the largest revenue share of 79.1% in 2023 owing to the high demand among healthcare practitioners and patients for medicinal marijuana.
  • By product type, oil and tinctures held the largest market share in 2023 owing to low price and ease of accessibility of flowers compared to other products.
  • In 2023, North America dominated the overall market with a revenue share of 76% owing to its large consumer base, North America was among the first regions to legalize the use of medical and recreational cannabis.

Table of Contents

Chapter 1. Legal Marijuana Market: Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Application
1.2.2. Product Type
1.2.3. Regional Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Legal Marijuana Market: Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. Product type outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Legal Marijuana Market: Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing adoption of medical marijuana for treatment of chronic diseases
3.2.1.2. Growing legalization of medical marijuana in various countries
3.2.1.3. Elimination of black market through legalization of medical marijuana
3.2.1.4. Impending legalization of marijuana for recreational/adult use
3.2.2. Market restraint analysis
3.2.2.1. Lower market access of marijuana due to absence of legalization programs in several Asian and African countries
3.2.2.2. Legalization of medical marijuana only for selected indications
3.2.2.3. Supply shortage of medical marijuana in various countries
3.3. Legal Marijuana Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Legal Marijuana Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Legal Marijuana Market by Application Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Medical
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Cancer
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Chronic Pain
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.4. Depression and Anxiety
4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.5. Arthritis
4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.6. Diabetes
4.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.7. Glaucoma
4.4.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.8. Migraines
4.4.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.9. Epilepsy
4.4.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.10. Multiple Sclerosis
4.4.1.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.11. AIDS
4.4.1.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.12. Amyotrophic Lateral Sclerosis
4.4.1.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.13. Alzheimer’s
4.4.1.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.14. Post-Traumatic Stress Disorder (PTSD)
4.4.1.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.15. Parkinson's
4.4.1.15.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.16. Tourette’s
4.4.1.16.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.17. Others
4.4.1.17.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Adult Use
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Legal Marijuana Market: Product Type Estimates & Trend Analysis
5.1. Product Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Legal Marijuana Market by Product Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Flower
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Oil and tinctures
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Legal Marijuana Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Netherlands
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
6.6.6. Croatia
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
6.6.7. Poland
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
6.6.8. Czech Republic
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.6.9. Switzerland
6.6.9.1. Key country dynamics
6.6.9.2. Regulatory framework/ reimbursement structure
6.6.9.3. Competitive scenario
6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Asia-Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.5. New Zealand
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Colombia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.8.4. Colombia
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework/ reimbursement structure
6.8.4.3. Competitive scenario
6.8.4.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Isarel
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Canopy Growth Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. AURORA CANNABIS INC.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Tilray Brands Inc. (Aphria, Inc.)
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. The Cronos Group
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. MARICANN INC.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Organigram Holdings Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Lexaria Bioscience
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Tikun Olam
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. United Cannabis Corporation
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America legal marijuana market, by region, 2018-2030 (USD Million)
Table 3 North America legal marijuana market, by application, 2018-2030 (USD Million)
Table 4 North America legal marijuana market, by product type, 2018-2030 (USD Million)
Table 5 U.S. legal marijuana market, by application, 2018-2030 (USD Million)
Table 6 U.S. legal marijuana market, by product type, 2018-2030 (USD Million)
Table 7 Canada legal marijuana market, by application, 2018-2030 (USD Million)
Table 8 Canada legal marijuana market, by product type, 2018-2030 (USD Million)
Table 9 Europe legal marijuana market, by region, 2018-2030 (USD Million)
Table 10 Europe legal marijuana market, by application, 2018-2030 (USD Million)
Table 11 Europe legal marijuana market, by product type, 2018-2030 (USD Million)
Table 12 Germany legal marijuana market, by application, 2018-2030 (USD Million)
Table 13 Germany legal marijuana market, by product type, 2018-2030 (USD Million)
Table 14 UK legal marijuana market, by application, 2018-2030 (USD Million)
Table 15 UK legal marijuana market, by product type, 2018-2030 (USD Million)
Table 16 Netherlands legal marijuana market, by application, 2018-2030 (USD Million)
Table 17 Netherlands legal marijuana market, by product type, 2018-2030 (USD Million)
Table 18 Italy legal marijuana market, by application, 2018-2030 (USD Million)
Table 19 Italy legal marijuana market, by product type, 2018-2030 (USD Million)
Table 20 Spain legal marijuana market, by application, 2018-2030 (USD Million)
Table 21 Spain legal marijuana market, by product type, 2018-2030 (USD Million)
Table 22 Croatia legal marijuana market, by application, 2018-2030 (USD Million)
Table 23 Croatia legal marijuana market, by product type, 2018-2030 (USD Million)
Table 24 Poland legal marijuana market, by application, 2018-2030 (USD Million)
Table 25 Poland legal marijuana market, by product type, 2018-2030 (USD Million)
Table 26 Czech Republic legal marijuana market, by application, 2018-2030 (USD Million)
Table 27 Czech Republic legal marijuana market, by product type, 2018-2030 (USD Million)
Table 28 Switzerland legal marijuana market, by application, 2018-2030 (USD Million)
Table 29 Switzerland legal marijuana market, by product type, 2018-2030 (USD Million)
Table 30 Asia-Pacific legal marijuana market, by region, 2018-2030 (USD Million)
Table 31 Asia-Pacific legal marijuana market, by application, 2018-2030 (USD Million)
Table 32 Asia-Pacific legal marijuana market, by product type, 2018-2030 (USD Million)
Table 33 China legal marijuana market, by application, 2018-2030 (USD Million)
Table 34 China legal marijuana market, by product type, 2018-2030 (USD Million)
Table 35 Japan legal marijuana market, by application, 2018-2030 (USD Million)
Table 36 Japan legal marijuana market, by product type, 2018-2030 (USD Million)
Table 37 India legal marijuana market, by application, 2018-2030 (USD Million)
Table 38 India legal marijuana market, by product type, 2018-2030 (USD Million)
Table 39 New Zealand legal marijuana market, by application, 2018-2030 (USD Million)
Table 40 New Zealand legal marijuana market, by product type, 2018-2030 (USD Million)
Table 41 Australia legal marijuana market, by application, 2018-2030 (USD Million)
Table 42 Australia legal marijuana market, by product type, 2018-2030 (USD Million)
Table 43 Thailand legal marijuana market, by application, 2018-2030 (USD Million)
Table 44 Thailand legal marijuana market, by product type, 2018-2030 (USD Million)
Table 45 Latin America legal marijuana market, by application, 2018-2030 (USD Million)
Table 46 Latin America legal marijuana market, by product type, 2018-2030 (USD Million)
Table 47 Latin America legal marijuana market, by application, 2018-2030 (USD Million)
Table 48 Brazil legal marijuana market, by application, 2018-2030 (USD Million)
Table 49 Brazil legal marijuana market, by product type, 2018-2030 (USD Million)
Table 50 Mexico legal marijuana market, by application, 2018-2030 (USD Million)
Table 51 Mexico legal marijuana market, by product type, 2018-2030 (USD Million)
Table 52 Uruguay legal marijuana market, by application, 2018-2030 (USD Million)
Table 53 Uruguay legal marijuana market, by product type, 2018-2030 (USD Million)
Table 54 Colombia legal marijuana market, by application, 2018-2030 (USD Million)
Table 55 Colombia legal marijuana market, by product type, 2018-2030 (USD Million)
Table 56 MEA legal marijuana market, by region, 2018-2030 (USD Million)
Table 57 MEA legal marijuana market, by application, 2018-2030 (USD Million)
Table 58 MEA legal marijuana market, by product type, 2018-2030 (USD Million)
Table 59 South Africa legal marijuana market, by application, 2018-2030 (USD Million)
Table 60 South Africa legal marijuana market, by product type, 2018-2030 (USD Million)
Table 61 Israel legal marijuana market, by application, 2018-2030 (USD Million)
Table 62 Israel legal marijuana market, by product type, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Legal marijuana market: market outlook
Fig. 9 Legal marijuana competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Legal marijuana market driver impact
Fig. 15 Legal marijuana market restraint impact
Fig. 16 Legal marijuana market strategic initiatives analysis
Fig. 17 Legal marijuana market: Application movement analysis
Fig. 18 Legal marijuana market: Application outlook and key takeaways
Fig. 19 Medical market estimates and forecast, 2018-2030
Fig. 20 Chronic Pain market estimates and forecast, 2018-2030
Fig. 21 Cryoablation market estimates and forecast, 2018-2030
Fig. 22 Cancer market estimates and forecast, 2018-2030
Fig. 23 Depression and Anxiety market estimates and forecast, 2018-2030
Fig. 24 Arthritis market estimates and forecast, 2018-2030
Fig. 25 Diabetes market estimates and forecast, 2018-2030
Fig. 26 Glaucoma market estimates and forecast, 2018-2030
Fig. 27 Migraines market estimates and forecast, 2018-2030
Fig. 28 Epilepsy market estimates and forecast, 2018-2030
Fig. 29 Multiple Sclerosis market estimates and forecast, 2018-2030
Fig. 30 AIDS market estimates and forecast, 2018-2030
Fig. 31 Amyotrophic Lateral Sclerosis market estimates and forecast, 2018-2030
Fig. 32 Post-traumatic Stress Disorder (PTSD) market estimates and forecast, 2018-2030
Fig. 33 Parkinson's market estimates and forecast, 2018-2030
Fig. 34 Tourette’s market estimates and forecast, 2018-2030
Fig. 35 Others market estimates and forecast, 2018-2030
Fig. 36 Adult Use market estimates and forecast, 2018-2030
Fig. 37 Legal marijuana Market: Product Type movement Analysis
Fig. 38 Legal marijuana market: Product Type outlook and key takeaways
Fig. 39 Flower market estimates and forecasts, 2018-2030
Fig. 40 Oil and Tinctures market estimates and forecasts, 2018-2030
Fig. 41 Global Legal marijuana market: Regional movement analysis
Fig. 42 Global Legal marijuana market: Regional outlook and key takeaways
Fig. 43 Global Legal marijuana market share and leading players
Fig. 44 North America market share and leading players
Fig. 45 Europe market share and leading players
Fig. 46 Asia-Pacific market share and leading players
Fig. 47 Latin America market share and leading players
Fig. 48 Middle East & Africa market share and leading players
Fig. 49 North America, by country
Fig. 50 North America
Fig. 51 North America market estimates and forecasts, 2018-2030
Fig. 52 U.S.
Fig. 53 U.S. market estimates and forecasts, 2018-2030
Fig. 54 Canada
Fig. 55 Canada market estimates and forecasts, 2018-2030
Fig. 56 Europe
Fig. 57 Europe market estimates and forecasts, 2018-2030
Fig. 58 UK
Fig. 59 UK market estimates and forecasts, 2018-2030
Fig. 60 Germany
Fig. 61 Germany market estimates and forecasts, 2018-2030
Fig. 62 Netherlands
Fig. 63 Netherlands market estimates and forecasts, 2018-2030
Fig. 64 Italy
Fig. 65 Italy market estimates and forecasts, 2018-2030
Fig. 66 Spain
Fig. 67 Spain market estimates and forecasts, 2018-2030
Fig. 68 Croatia
Fig. 69 Croatia market estimates and forecasts, 2018-2030
Fig. 70 Poland
Fig. 71 Poland market estimates and forecasts, 2018-2030
Fig. 72 Czech Republic
Fig. 73 Czech Republic market estimates and forecasts, 2018-2030
Fig. 74 Switzerland
Fig. 75 Switzerland market estimates and forecasts, 2018-2030
Fig. 76 Asia-Pacific
Fig. 77 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 78 China
Fig. 79 China market estimates and forecasts, 2018-2030
Fig. 80 Japan
Fig. 81 Japan market estimates and forecasts, 2018-2030
Fig. 82 India
Fig. 83 India market estimates and forecasts, 2018-2030
Fig. 84 Thailand
Fig. 85 Thailand market estimates and forecasts, 2018-2030
Fig. 86 New Zealand
Fig. 87 New Zealand market estimates and forecasts, 2018-2030
Fig. 88 Australia
Fig. 89 Australia market estimates and forecasts, 2018-2030
Fig. 90 Latin America
Fig. 91 Latin America market estimates and forecasts, 2018-2030
Fig. 92 Brazil
Fig. 93 Brazil market estimates and forecasts, 2018-2030
Fig. 94 Mexico
Fig. 95 Mexico market estimates and forecasts, 2018-2030
Fig. 96 Colombia
Fig. 97 Colombia market estimates and forecasts, 2018-2030
Fig. 98 Uruguay
Fig. 99 Uruguay market estimates and forecasts, 2018-2030
Fig. 100 Middle East and Africa
Fig. 101 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 102 South Africa
Fig. 103 South Africa market estimates and forecasts, 2018-2030
Fig. 104 Israel
Fig. 105 Israel Arabia market estimates and forecasts, 2018-2030
Fig. 106 Market share of key market players- Legal marijuana market

Companies Mentioned

  • Canopy Growth Corporation
  • AURORA CANNABIS INC.
  • Tilray Brands Inc. (Aphria, Inc.)
  • ABcann Medicinals, Inc. (VIVO Cannabis Inc.)
  • The Cronos Group
  • MARICANN INC.
  • Organigram Holdings Inc.
  • Lexaria Bioscience
  • GW Pharmaceuticals (Jazz Pharmaceuticals, Inc.)
  • Tikun Olam
  • United Cannabis Corporation

Table Information

Report AttributeDetails
No. of Pages125
PublishedJanuary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 21 Billion
Forecasted Market Value ( USD ) by 2030 $ 102.24 Billion
Compound Annual Growth Rate25.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Legal Marijuana Market by Product Type, Application, Route of Administration, Distribution Channel, Consumer Age Group - Global Forecast to 2030 - Product Image

Legal Marijuana Market by Product Type, Application, Route of Administration, Distribution Channel, Consumer Age Group - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Marijuana Market by Distribution Channel, Consumption Method, Application, Product Type, Source - Global Forecast to 2030 - Product Image

Marijuana Market by Distribution Channel, Consumption Method, Application, Product Type, Source - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Legal Marijuana - Global Strategic Business Report - Product Image

Legal Marijuana - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Legal Marijuana Market Report and Forecast 2025-2034 - Product Image

Legal Marijuana Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Legal Marijuana Market 2024 - Product Image

Legal Marijuana Market 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.